Plasma Levels of Enzalutamide and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer Undergoing Hemodialysis
Publication date
2019-04
Authors
van Nuland, Merel
Groenland, Steffie
Bergman, Andre M
Rotmans, Joris I
Rosing, Hilde
Beijnen, Jos
Huitema, Alwin D R
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
Keywords
enzalutamide, hemodioalysis, metabolites, prostate cancer, renal failure, SDG 3 - Good Health and Well-being
Citation
van Nuland, M, Groenland, S, Bergman, A M, Rotmans, J I, Rosing, H, Beijnen, J H & Huitema, A D R 2019, 'Plasma Levels of Enzalutamide and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer Undergoing Hemodialysis', Clinical Genitourinary Cancer, vol. 17, no. 2, pp. e383-e386. https://doi.org/10.1016/j.clgc.2018.12.004